<p>The research conducted by Tolle et al. sheds light on the rising rates of blood culture contaminations (BCC) during and after the COVID-19 pandemic. However, there are several important areas that need more attention to make the study more relevant and impactful. This letter points out some key issues, such as how the training of less experienced staff might affect BCC rates, the risk of misclassification bias even with set classification criteria, the lack of patient-specific risk assessments, and the absence of procedural audits to check for failures in aseptic techniques. It’s well-known that having trained personnel can help lower BCC rates, which suggests that simply having staff turnover might not explain the increase we’ve seen. Moreover, misclassifying contaminants as actual infections—or the other way around—can lead to serious clinical consequences, like unnecessary antibiotic prescriptions and higher healthcare costs. Additionally, certain high-risk groups, such as patients with central venous catheters or chronic conditions, might be more affected by BCC, but the study doesn’t take these factors into account. Finally, without observational audits, it’s hard to determine if procedural mistakes or other outside factors played a role in the rise of contamination rates. Tackling these issues is essential for improving blood culture practices, boosting diagnostic accuracy, and reducing the unintended effects of BCC in healthcare settings after the pandemic. Future research should focus on thorough assessments of staff training, risk stratification models, and real-time audits of procedures to create targeted strategies aimed at lowering contamination rates and enhancing patient outcomes.</p>